MOLNDAL, Sweden, Aug. 7 (UPI) -- A Swedish-led team of scientists is developing a âtool kitâ for personalized medicine based on a personâs genetic characteristics.
Fredrik Nyberg, Gyorgy Marko-Varga, Atsushi Ogiwara and colleagues at AstraZenecaâs research and development center in Molndal, Sweden, note cancer therapy already is moving toward individualized treatments selected according to tumor cell type and patientsâ predicted responses to different kinds of anti-cancer drugs.
The researchers have developed a system of state-of-the-art proteomic profiling, in which blood tests are used to analyze single proteins and multiple âfingerprintâ protein patterns, including proteins that can serve as biomarkers for disease.
The aim is to create a âtool kitâ that physicians could use in everyday medicine, including rapid methods for identifying proteins in the blood and processing the resulting data.
The project is presented in the current issue of the Journal of Proteome Research.